In: Angiogenesis, 2014, vol. 17, no. 3, p. 519-527
|
In: Journal of Cancer Research and Clinical Oncology, 2013, vol. 139, no. 8, p. 1295-1302
|
In: Virchows Archiv, 2007, vol. 451, no. 4, p. 763-769
|
In: Virchows Archiv, 2008, vol. 453, no. 6, p. 579-588
|
In: World Journal of Surgery, 2012, vol. 36, no. 10, p. 2300-2304
|
In: Carcinogenesis, 2014, vol. 35, no. 1, p. 114-122
|
In: Antimicrobial Agents and Chemotherapy, 2016, p. AAC.02934–15
Implant-associated infections (IAI) are a dreaded complication mainly caused by biofilm-forming staphylococci. Implant surfaces preventing microbial colonization would be desirable. We examined the preventive effect of a silver-coated titanium aluminium niobium (TiAlNb) alloy. The surface elicited a strong, inoculum-dependent activity against Staphylococcus (S.) epidermidis and S. aureus in an...
|
In: Molecular Cancer Therapeutics, 2011, vol. 10, no. 6, p. 1007-1017
Sorafenib targets the Raf/mitogen activated protein kinase, VEGF and PDGF pathways and prolongs survival patients in advanced hepatocellular carcinoma (HCC). Everolimus inhibits the mammalian target of rapamycin, a kinase overactive in HCC. To investigate whether the antitumor effects of these agents are additive, we compared a combined and sequential treatment regimen of everolimus and...
|